2013 Development Gordon Innovation 
N2Growth Blog
AUGUST 1, 2016
Gordon Berridge: Our readers, with mining knowledge, will be will be familiar with the name Sam Walsh and Rio Tinto, but to provide a complete sketch of your background, would you please share a brief summary of your career history? Gordon Berridge: Would you please share what first attracted you to join Rio Tinto back in 1991?
The Horizons Tracker
FEBRUARY 5, 2020
It’s an argument that economists such as Robert Gordon believe carries little weight, and the problem is not so much that the various benefits provided by the technologies of the 4th industrial revolution cannot be captured, but that the technologies themselves are not utilized enough. in 2013, compared to 2.5%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
NOVEMBER 4, 2014
Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. In one analysis , Gordon D.
Harvard Business Review
NOVEMBER 4, 2014
Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. In one analysis , Gordon D.
Deming Institute
FEBRUARY 11, 2016
For more than 10 years now I have been helping people to develop their own Small and Medium-sized Enterprises (SME). Many of the clients I worked with had had developed the idea for years, but they were reluctant to quit their Jobs, or were afraid of failing. Even myself, by 2013 I was still working for a Company.
Expert insights. Personalized for you.
150 
Let's personalize your content